المعالجة الدوائية للطنين

Authors

  • محمد الرستم
  • مصطفى إبراهيم
  • ابتهال حاج بكري

Abstract

يعد الطنين من أهم الشكاوى التي تدعو لاستشارة أخصائي الأذن والأنف والحنجرة وهو يمثل مشكلة تشخيصية وعلاجية معقدة ويجب أن تتم دراسة المريض بشكل جيد ودقيق لتحديد سبب الطنين إن أمكن والهدف من الدراسة هو التوصل إلى علاج للطنين من خلال المقارنة بين الحقن الموضعي الميتيل بريدينزولون (40مغ/1سم³ ) ضمن الأذن مع المعالجة الدوائية بالكاربامازيبين بجرعات متزايدة من(100مغ 3 مرات يومياً) وقد نصل إلى 600أو 1200 مع\ اليوم حيث شملت الدراسة 150 مريضاً يعانون من الطنين من مراجعي العيادة الأذنية في مشفى الأسد الجامعي  وبعد مراقبة المرضى استطعنا أن نقيم النتائج العلاجية وقد أظهرت دراستنا فعالية جيدة للكاربامازيبين أكثر قليلاً من الميتيل بريدنيزولون إضافة إلى ذلك آثاره الجانبية متحملة إلى حد كبير ومشاركتهما معاً زادت نسبة التحسن قليلاً .

Tinnitus is considered to be one of the most important diseases in E.N.T. It represents a complicated diagnostic and therapeutic problem. We must examine the patient carefully to reach the reason.  This study is designed to find an effective treatment of tinnitus through comparison between Intratympanic instillation of Methylprednisolone (40mg/1cc) and medical treatment with Carbamazepine in increased doses from 100mg three times a day to 600 or 1200 mg a day divided into three doses. The study involved (150) patients from Alassad Hospital ,E.N.T. clinic. After the observation we find that Carbamazepine is a good treatment and the combination between them has better results

Downloads

Published

2019-01-17

How to Cite

1.
الرستم م, إبراهيم م, حاج بكري ا. المعالجة الدوائية للطنين. Tuj-hlth [Internet]. 2019Jan.17 [cited 2024May10];30(3). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/6546

Issue

Vol. 30 No. 3 (2008): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)

1 2 > >>